Navigation Links
Nanobiosym awarded $2 million DTRA contract
Date:9/26/2007

MEDFORD, Mass., September 26, 2007 Nanobiosym Inc., announced today that it has been awarded a highly competitive $2 million contract from the United States Defense Threat Reduction Agency (DTRA), a branch of the US Department of Defense. The winners of this award were selected after an intense competition among many of the nations leading US academic, government, and industrial labs.

Nanobiosym, and its commercial partner Nanobiosym Diagnostics, have been privately developing Gene-RADAR, a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism. The companys vision is to give patients worldwide real-time access to their own diagnostic information via low-cost handheld devices. Nanobiosym Diagnostics also seeks to leverage its nanotechnology platform to enable portable real-time detection of food and air-borne pathogens, as well as water testing, animal and crop testing, and screening of blood and transplant organs.

We are delighted that DTRA has recognized our unique proprietary technological platform with this award, said Dr. Anita Goel, M.D., PhD., Chairman and CEO of Nanobiosym. This is our first defense contract and is a major step towards establishing the US government as one of our long-term customers. Nanobiosym has been previously recognized by several other prominent awards, including multiple rounds of funding from the Defense Advance Research Project Agency (DARPA), the Air Force Office of Scientific Research (AFOSR), and the U.S. Department of Energy (DOE). Nanobiosym shares DTRAs strategic mission to reduce the threat of biological warfare and bioterrorism and during the course of the DTRA contract plans to validate the use of Nanobiosyms proprietary technology platform for emerging biodefense applications. In the coming years, we envision a significant paradigm shift in healthcare where the ability to diagnose disease is taken out of a pathology lab and brought into doctors clinics, peoples homes, and even rural villages. said Dr. Goel. This is similar to the paradigm shift that occurred in the telecom industry when communications and computing devices became portable. Nanobiosym is also actively adapting its Gene-RADAR system to address unmet healthcare needs in the developing world, where the lack of basic infrastructure often precludes effective diagnostics.


'/>"/>

Contact: NBS Media & Public Relations
Info@nanobiosym.com
781-391-7979
Feinstein Kean Healthcare
Source:Eurekalert

Related biology news :

1. TGen awarded $7.1 million to accelerate brain disease research
2. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
3. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
4. Six million Africans face famine because of locusts, drought
5. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
6. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
7. $5.1 billion would save 6 million children
8. Health costs soar as 60 million Americans classed as obese
9. Malaria killing a million a year
10. $6.5 Million Grant for Microarray Center at Yale School of Medicine
11. MSU researchers receive $4 million grant to uncover gene functions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... 2017 Mintigo , the leader ... Predictive Sales Coach TM , its new artificial ... into Salesforce. This unique AI application will allow ... with deep knowledge of their customers and prospects ... Predictive Sales Coach extends Mintigo,s existing customer success ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... 23, 2017 , ... Ellen Matloff, president and CEO of ... as a 2017 Women of Innovation® finalist. Matloff will be among several women ... The dinner recognizes women accomplished in science, technology, engineering and math (STEM), along ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
(Date:3/22/2017)... March 22, 2017 MarketNewsUpdates.com News Commentary  ... The ... are being pressured as of late due to the rise ... management has a dramatic impact on patient,s quality of life ... activities for identifying new forms of opioid formulations that prevent ...
Breaking Biology Technology: